-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
FY2022 EPS Estimates for Avivagen Inc. Decreased by Zacks Small Cap (OTCMKTS:VIVXF)
FY2022 EPS Estimates for Avivagen Inc. Decreased by Zacks Small Cap (OTCMKTS:VIVXF)
Avivagen Inc. (OTCMKTS:VIVXF – Get Rating) – Investment analysts at Zacks Small Cap reduced their FY2022 EPS estimates for shares of Avivagen in a note issued to investors on Wednesday, August 31st. Zacks Small Cap analyst D. Bautz now anticipates that the company will earn ($0.08) per share for the year, down from their prior estimate of ($0.07). The consensus estimate for Avivagen's current full-year earnings is ($0.07) per share.
Get Avivagen alerts:Avivagen (OTCMKTS:VIVXF – Get Rating) last announced its quarterly earnings results on Wednesday, June 15th. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02). The company had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.23 million.
Avivagen Price Performance
Shares of OTCMKTS:VIVXF opened at $0.13 on Friday. The company's 50 day moving average price is $0.14 and its two-hundred day moving average price is $0.15. Avivagen has a 12-month low of $0.12 and a 12-month high of $0.38. The firm has a market cap of $9.33 million, a PE ratio of -1.40 and a beta of 0.13.About Avivagen
(Get Rating)
Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.
See Also
- Get a free copy of the StockNews.com research report on Avivagen (VIVXF)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.
Avivagen Inc. (OTCMKTS:VIVXF – Get Rating) – Investment analysts at Zacks Small Cap reduced their FY2022 EPS estimates for shares of Avivagen in a note issued to investors on Wednesday, August 31st. Zacks Small Cap analyst D. Bautz now anticipates that the company will earn ($0.08) per share for the year, down from their prior estimate of ($0.07). The consensus estimate for Avivagen's current full-year earnings is ($0.07) per share.
Avivagen Inc.(OTCMKTS：VIVXF-GET Rating)-Zack Small Cap的投资分析师在8月31日星期三发给投资者的一份报告中下调了对Avivagen股票的2022财年每股收益预期。扎克斯小盘分析师D.Bautz现在预计，该公司今年的每股收益将为0.08美元，低于此前预测的0.07美元。对英杰华目前全年收益的普遍预期为每股0.07美元。
Avivagen (OTCMKTS:VIVXF – Get Rating) last announced its quarterly earnings results on Wednesday, June 15th. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02). The company had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.23 million.
Avivagen(OTCMKTS：VIVXF-GET Rating)上一次公布季度收益是在6月15日星期三。该公司公布该季度每股收益为0.02美元，符合分析师一致预期的0.02美元。该公司本季度营收为70万美元，而分析师预期为23万美元。
Avivagen Price Performance
Avivagen性价比
About Avivagen
关于英杰华
(Get Rating)
(获取评级)
Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.
Avivagen Inc是一家生命科学公司，专注于开发家畜饲料产品并将其商业化，这些产品支持免疫功能，帮助动物实现生长和生产力。该公司提供OXC-beta牲畜，这是一种预混料，用于牲畜饲料；
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Avivagen (VIVXF)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免费获取StockNews.com关于Avivagen的研究报告(VIVXF)
- 随着管理层重组，股市能否迅速反弹？
- MarketBeat：回顾中的一周8/29-9/2
- 霍梅尔在这些水平上看起来很便宜
- 露露柠檬将飙升至9月
- 耐克股票会被超卖，但仍被高估吗？
Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.
接受Avivagen Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Avivagen和相关公司的最新新闻和分析师评级的每日简明摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧